MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Pilot Study to Assess Mean Lesion Stiffness of Radiation Necrosis and Recurrent Glioma Using Magnetic Resonance Elastography (MRE) in Patients With Previously Treated Gliomas
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria * \>/=18 years old. * History of a pathology proven intracranial glioma (including IDH mutant, IDH wildtype or 1p19q co-deleted tumors) treated with chemotherapy and radiation. * The lesion of concern (T2 Flair Hyperintense or contrast enhancing lesion) is \> 2 cm * Patient is able to understand and give consent to participation in the study. Exclusion Criteria * Patients less than 18 years of age. * Pregnant. * Known allergy to gadolinium-based contrast agents. * Renal failure as evidenced by a glomerular filtration rate (GFR) of less than 30 mL/min/1.73m2. * Pacemakers, electronic stimulation, metallic foreign bodies and devices and/or other conditions that are not MR safe, which include but are not limited to: * electronically, magnetically, and mechanically activated implants * ferromagnetic or electronically operated active devices like automatic cardioverter defibrillators and cardiac pacemakers * metallic splinters in the eye * ferromagnetic hemostatic clips in the central nervous system (CNS) or body * cochlear implants * other pacemakers, e.g., for the carotid sinus * insulin pumps and nerve stimulators * non-MR safe lead wires * prosthetic heart valves (if dehiscence is suspected) * non-ferromagnetic stapedial implants * claustrophobia that does not readily respond to oral medication
About the study
This trial uses magnetic resonance elastography (MRE) to estimate tissue stiffness (hardness or softness of the tissue) in tissue that is affected by radiation treatment (radiation necrosis) and tumor tissue that has come back (recurrent) after treatment in patients with gliomas. Diagnostic procedures, such as MRE, may estimate the differences in tissue stiffness between radiation necrosis and recurrent glioma post treatment and ultimately lead to a more accurate diagnosis and/or surgery, and/or a better assessment of the disease's response to treatment.
What is being tested
- Magnetic Resonance Elastography (procedure)
- Magnetic Resonance Imaging (procedure)
Sponsor: M.D. Anderson Cancer Center · Participants: 80 · Started: Mar 20, 2020
Contact the study team
- Melissa Chen, MD · Phone: 713-745-9789
Official record on ClinicalTrials.gov — NCT04373720
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.